Lisa, who has found global success as a Blackpink member and solo star, will be featured in a documentary from Sony Music ...

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of ...

Through their nonprofit, Neighborhood Villages, the two women are reimagining the state's approach to early education, with ...

As a public school art teacher in Rochester, Minnesota, Kate Erwin spent eight years teaching students to see the world ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S. market in the third quarter of 2025. International rollouts are expected to ...

The University of Houston has received a generous $1.1 million gift from the Austin-based Cynthia and George Mitchell ...

Minis For War commission painting studio explains how it got such vibrant colors for this Care Bear inspired Star Wars Legion ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

Light therapy may support the skin’s natural renewal process, contributing to a smoother and more radiant under-eye area.